
zzso On the 29th of October 2003, zzso was approved by the zzso health agency zzso zzso zzso de zzso zzso des zzso de zzso for its use in the aggressive forms of multiple sclerosis zzso It is the first zzso having demonstrated particular efficacy in this progressive form of zzso Definition of aggressive zzso zzso multiple sclerosis is defined as an zzso that leads to the rapid zzso of disabilities, whether these latter are the result of repeated relapses (at least 2 in the past 12 zzso or the continuous progression of a disability zzso in 2 points on the expanded disability status scale zzso in the past 12 zzso The benefits of zzso In cases of aggressive multiple zzso zzso (20 zzso zzso administered in Monthly cycles for 6 zzso clearly reduces the frequency of zzso the appearance of new zzso on zzso and the progression of the zzso zzso to be taken when using zzso The side effects however justify the fact that this drug is limited to the aggressive forms of zzso zzso toxicity limits the duration of the prescription and the maximum dose zzso requiring strict zzso zzso Its unpredictable zzso toxicity can be devastating zzso of subsequent zzso The zzso ratio must be discussed with the patient and a zzso zzso and three Monthly blood count must be continued during the 5 Years following withdrawal of zzso The prescription of zzso is limited to the zzso of departments specialized in zzso 

